Protein Kinase Inhibitors as a New Target for Immune System Modulation and Brain Cancer Management

High-grade brain tumors are malignant tumors with poor survival and remain the most difficult tumors to treat. An important contributing factor to the development and progression of brain tumors is their ability to evade the immune system. Several immunotherapeutic strategies including vaccines and...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippone, Alessia, Mannino, Deborah, Casili, Giovanna, Lanza, Marika, Paterniti, Irene, Cuzzocrea, Salvatore, Capra, Anna Paola, Colarossi, Lorenzo, Giuffrida, Dario, Lombardo, Sofia Paola, Esposito, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778944/
https://www.ncbi.nlm.nih.gov/pubmed/36555334
http://dx.doi.org/10.3390/ijms232415693

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778944/
https://www.ncbi.nlm.nih.gov/pubmed/36555334
http://dx.doi.org/10.3390/ijms232415693

Ejemplares similares